Latest from the Blog

1. June 25, 2020

   NBTS Brain Tumor Clinical Trials Report: Q2 2020

   

   It can be hard for patients and care partners to keep track of new clinical trial opportunities opening across the country, especially during the current public health crisis created by the coronavirus (COVID-19). However, there are many brain tumor clinical trials still actively enrolling patients, and this report provides a summary of the studies that […]

   Read more | 

   Tags: brain cancer, brain tumor, chemotherapy, Clinical trials, DIPG, GBM, glioblastoma, glioma, high-grade glioma, immunotherapy, low-grade glioma, Medulloblastoma, meningioma, neurosurgery, Oligodendroglioma, pediatric brain tumor, precision medicine, Treatment
2. June 5, 2020

   Reflections on the Two-Year Anniversary of The Childhood Cancer STAR Act

   

   Two years ago, I stood in the Oval Office and watched as the Childhood Cancer STAR Act was signed into law. Observing this historic moment, I thought of the thousands of advocates, organizations, and children who worked tirelessly to support this legislation. From the first roundtable with the Alliance for Childhood Cancer, Coalition Against Childhood […]

   Read more | 

   Tags: childhood cancer, Community, NCI, pediatric, pediatric brain tumor, pediatric cancer, pediatrics, Treatment
3. May 31, 2020

   [RECAP] Brain Tumor Awareness Month 2020

   

   Brain Tumor Awareness Month 2020 was bound to be a little different. The unprecedented nature of the COVID-19 public health crisis upended daily life for all Americans, including the brain tumor community, where the impact cut many ways.  However, what we saw these past 31 days has been remarkable (if not completely unexpected). Despite many […]

   Read more | 

   Tags: advocacy, brain cancer, brain tumor, Brain Tumor Awareness Month, brain tumor community, BTAM, Community